Bioteque Corporation (4107.TWO)
TWD 110.0
(-0.9%)
TWD 110.0
(-0.9%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.43 Billion TWD | -1.26% |
| 2022 | 1.44 Billion TWD | 36.95% |
| 2021 | 1.05 Billion TWD | 17.58% |
| 2020 | 899.54 Million TWD | 98.85% |
| 2019 | 452.37 Million TWD | -1.12% |
| 2018 | 457.51 Million TWD | -5.61% |
| 2017 | 484.69 Million TWD | -0.35% |
| 2016 | 486.4 Million TWD | -19.75% |
| 2015 | 606.12 Million TWD | 30.29% |
| 2014 | 465.2 Million TWD | 22.08% |
| 2013 | 381.05 Million TWD | 11.13% |
| 2012 | 342.89 Million TWD | -11.48% |
| 2011 | 387.34 Million TWD | -12.33% |
| 2010 | 441.82 Million TWD | -6.84% |
| 2009 | 474.28 Million TWD | -11.44% |
| 2008 | 535.56 Million TWD | 11.95% |
| 2007 | 478.39 Million TWD | -9.85% |
| 2006 | 530.68 Million TWD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.68 Billion TWD | -2.48% |
| 2024 Q1 | 1.72 Billion TWD | 20.75% |
| 2023 FY | 1.43 Billion TWD | -1.26% |
| 2023 Q3 | 1.4 Billion TWD | -15.21% |
| 2023 Q1 | 1.69 Billion TWD | 17.01% |
| 2023 Q2 | 1.65 Billion TWD | -2.52% |
| 2023 Q4 | 1.43 Billion TWD | 2.09% |
| 2022 Q2 | 1.35 Billion TWD | 0.32% |
| 2022 Q1 | 1.35 Billion TWD | 27.85% |
| 2022 FY | 1.44 Billion TWD | 36.95% |
| 2022 Q3 | 1.34 Billion TWD | -1.1% |
| 2022 Q4 | 1.44 Billion TWD | 7.96% |
| 2021 Q1 | 916.42 Million TWD | 1.88% |
| 2021 Q3 | 962.37 Million TWD | -1.69% |
| 2021 Q4 | 1.05 Billion TWD | 9.9% |
| 2021 FY | 1.05 Billion TWD | 17.58% |
| 2021 Q2 | 978.94 Million TWD | 6.82% |
| 2020 Q3 | 828.98 Million TWD | 0.81% |
| 2020 Q1 | 477.81 Million TWD | 5.63% |
| 2020 FY | 899.54 Million TWD | 98.85% |
| 2020 Q2 | 822.29 Million TWD | 72.09% |
| 2020 Q4 | 899.54 Million TWD | 8.51% |
| 2019 Q3 | 545.08 Million TWD | -32.32% |
| 2019 Q4 | 452.37 Million TWD | -17.01% |
| 2019 FY | 452.37 Million TWD | -1.12% |
| 2019 Q2 | 805.39 Million TWD | 63.99% |
| 2019 Q1 | 491.12 Million TWD | 7.35% |
| 2018 FY | 457.51 Million TWD | -5.61% |
| 2018 Q4 | 457.51 Million TWD | -5.78% |
| 2018 Q1 | 509.31 Million TWD | 5.08% |
| 2018 Q2 | 762.17 Million TWD | 49.65% |
| 2018 Q3 | 485.55 Million TWD | -36.29% |
| 2017 Q4 | 484.69 Million TWD | 1.26% |
| 2017 Q2 | 696.77 Million TWD | 46.88% |
| 2017 Q1 | 474.39 Million TWD | -2.47% |
| 2017 FY | 484.69 Million TWD | -0.35% |
| 2017 Q3 | 478.68 Million TWD | -31.3% |
| 2016 FY | 486.4 Million TWD | -19.75% |
| 2016 Q1 | 602.34 Million TWD | -0.62% |
| 2016 Q2 | 733.77 Million TWD | 21.82% |
| 2016 Q3 | 515.97 Million TWD | -29.68% |
| 2016 Q4 | 486.4 Million TWD | -5.73% |
| 2015 FY | 606.12 Million TWD | 30.29% |
| 2015 Q4 | 606.12 Million TWD | -7.99% |
| 2015 Q3 | 658.73 Million TWD | 0.56% |
| 2015 Q2 | 655.06 Million TWD | 30.54% |
| 2015 Q1 | 501.8 Million TWD | 7.87% |
| 2014 Q1 | 388.14 Million TWD | 1.86% |
| 2014 FY | 465.2 Million TWD | 22.08% |
| 2014 Q3 | 442.63 Million TWD | -24.17% |
| 2014 Q2 | 583.71 Million TWD | 50.38% |
| 2014 Q4 | 465.2 Million TWD | 5.1% |
| 2013 Q2 | 470.36 Million TWD | 23.46% |
| 2013 Q3 | 489.66 Million TWD | 4.1% |
| 2013 Q4 | 381.05 Million TWD | -22.18% |
| 2013 FY | 381.05 Million TWD | 11.13% |
| 2013 Q1 | 380.98 Million TWD | 11.11% |
| 2012 Q1 | 387.68 Million TWD | 0.09% |
| 2012 Q2 | 468.9 Million TWD | 20.95% |
| 2012 Q3 | 354.87 Million TWD | -24.32% |
| 2012 Q4 | 342.89 Million TWD | -3.38% |
| 2012 FY | 342.89 Million TWD | -11.48% |
| 2011 Q2 | 554.08 Million TWD | 30.21% |
| 2011 Q3 | 386.98 Million TWD | -30.16% |
| 2011 Q4 | 387.34 Million TWD | 0.09% |
| 2011 FY | 387.34 Million TWD | -12.33% |
| 2011 Q1 | 425.53 Million TWD | -3.69% |
| 2010 Q4 | 441.82 Million TWD | 0.0% |
| 2010 FY | 441.82 Million TWD | -6.84% |
| 2009 FY | 474.28 Million TWD | -11.44% |
| 2008 FY | 535.56 Million TWD | 11.95% |
| 2007 FY | 478.39 Million TWD | -9.85% |
| 2006 FY | 530.68 Million TWD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| St.Shine Optical Co.,Ltd. | 1.61 Billion TWD | 11.614% |
| Chi Sheng Pharma & Biotech Co., Ltd | 547.04 Million TWD | -161.45% |
| Sunder Biomedical Tech. Co., Ltd. | 669.39 Million TWD | -113.661% |
| BenQ Medical Technology Corporation | 2.53 Billion TWD | 43.51% |
| Pacific Hospital Supply Co., Ltd | 934.33 Million TWD | -53.076% |
| Unicon Optical Co., Ltd. | 568.1 Million TWD | -151.756% |
| Formosa Optical Technology Co.,Ltd. | 4.17 Billion TWD | 65.736% |
| Medeon Biodesign, Inc. | 375.65 Million TWD | -280.737% |
| Concord Medical Co., Ltd. | 470.7 Million TWD | -203.85% |
| Crystalvue Medical Corporation | 221.36 Million TWD | -546.101% |
| Perfect Medical Industry Co., Ltd. | 324.72 Million TWD | -340.452% |
| ICARES Medicus, Inc. | 239.79 Million TWD | -496.433% |
| Lagis Enterprise Co., Ltd. | 304.62 Million TWD | -369.51% |
| Amed Co., Ltd. | 459.81 Million TWD | -211.049% |